Scarica l'app Stockscreener
289.43
0.48%
1.38
Dopo l'orario di chiusura:
289.43
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$288.05
Aprire:
$286.83
Volume 24 ore:
187.65K
Relative Volume:
0.60
Capitalizzazione di mercato:
$6.37B
Reddito:
$2.58B
Utile/perdita netta:
$-778.69M
Rapporto P/E:
-10.59
EPS:
-27.33
Flusso di cassa netto:
$223.75M
1 W Prestazione:
-1.44%
1M Prestazione:
+4.56%
6M Prestazione:
+15.54%
1 anno Prestazione:
-12.54%
Intervallo 1D:
$278.77
$290.72
Intervallo di 1 settimana:
$278.77
$300.85
Portata 52W:
$211.43
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Nome
Bio Rad Laboratories Inc
Settore
Industria
Telefono
(510) 724-7000
Indirizzo
1000 ALFRED NOBEL DRIVE, HERCULES
Confronta BIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
289.43 | 7.87B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-03 | Downgrade | Citigroup | Buy → Neutral |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-06-16 | Iniziato | Wells Fargo | Overweight |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-01-28 | Reiterato | Citigroup | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2018-10-17 | Iniziato | Goldman | Buy |
| 2018-09-20 | Iniziato | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Downgrade | CL King | Buy → Neutral |
| 2017-07-13 | Iniziato | Wells Fargo | Outperform |
| 2017-06-28 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Hold |
| 2016-10-13 | Iniziato | CL King | Buy |
| 2015-05-06 | Reiterato | Jefferies | Buy |
| 2009-12-18 | Iniziato | Maxim Group | Buy |
| 2009-11-06 | Iniziato | Jefferies & Co | Buy |
| 2009-07-17 | Iniziato | Soleil | Buy |
| 2007-09-26 | Iniziato | Banc of America Sec | Buy |
| 2007-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mostra tutto
Bio Rad Laboratories Inc Borsa (BIO) Ultime notizie
Bio-Rad at Wells Fargo Conference: Strategic Growth Amid Challenges - Investing.com
Should You Buy Bio-Rad Laboratories? Analyzing Valuation and Growth Prospects - AInvest
When Should You Buy Bio-Rad Laboratories, Inc. (NYSE:BIO)? - Yahoo Finance
Will Bio Rad Laboratories Inc. price bounce be sustainableWeekly Market Report & Weekly Consistent Profit Watchlists - Newser
Real time breakdown of Bio Rad Laboratories Inc. stock performanceJuly 2025 Summary & Free Daily Entry Point Trade Alerts - Newser
What is Bio Rad Laboratories Inc.’s book value per share2025 Technical Patterns & Growth Focused Entry Reports - khodrobank.com
Is Bio Rad Laboratories Inc. a strong candidate for buy and hold2025 Sector Review & Fast Entry High Yield Tips - khodrobank.com
Will Bio Rad Laboratories Inc. outperform its industry peersJuly 2025 Setups & Daily Technical Forecast Reports - khodrobank.com
Heatmap analysis for Bio Rad Laboratories Inc. and competitorsBuy Signal & Fast Moving Stock Watchlists - Newser
Analyzing net buyer seller activity in Bio Rad Laboratories Inc.2025 Fundamental Recap & Safe Investment Capital Preservation Plans - Newser
Aug Macro: Is Bio Rad Laboratories Inc. stock risky to hold nowStock Surge & Verified Momentum Stock Ideas - khodrobank.com
RBC Raises Price Target on Bio-Rad Laboratories to $437 From $409, Keeps Outperform Rating - MarketScreener
Bio-Rad Laboratories (NYSE:BIO) Upgraded to Hold at Zacks Research - MarketBeat
Can swing trading help recover from Bio Rad Laboratories Inc. losses2025 Earnings Surprises & Fast Moving Market Watchlists - Newser
Risk adjusted return profile for Bio Rad Laboratories Inc. analyzedJuly 2025 PostEarnings & Safe Capital Investment Plans - Newser
Update Report: What’s next for Bio Rad Laboratories Inc. stockJuly 2025 Volume & Capital Protection Trade Alerts - khodrobank.com
What data driven models say about Bio Rad Laboratories Inc.’s futureBear Alert & Safe Capital Growth Stock Tips - Newser
Analyzing drawdowns of Bio Rad Laboratories Inc. with statistical toolsBreakout Watch & Weekly High Return Stock Forecasts - Newser
What’s the recovery path for long term holders of Bio Rad Laboratories Inc.Index Update & Safe Entry Zone Tips - Newser
What’s the RSI of Bio Rad Laboratories Inc. stock2025 Geopolitical Influence & Weekly Setup with High ROI Potential - خودرو بانک
Bio-Rad Laboratories Stock Soars 17.92% on Strong Financial Performance - AInvest
Is Bio-Rad Laboratories (BIO) Entering a Period of More Sustained Recovery? - Yahoo Finance
Can Bio Rad Laboratories Inc. rally from current levelsGold Moves & Fast Entry Momentum Trade Alerts - Newser
Why Bio Rad Laboratories Inc. stock attracts strong analyst attention2025 Retail Activity & Verified Entry Point Signals - Newser
Bio-Rad expands range of StarBright Dyes to enhance panel design capabilities for spectral flow cytometry - SelectScience
Will Bio Rad Laboratories Inc. rebound enough to break even2025 Top Decliners & AI Based Buy and Sell Signals - Newser
How to forecast Bio Rad Laboratories Inc. trends using time seriesJuly 2025 Outlook & Growth Oriented Trade Recommendations - Newser
What are Bio Rad Laboratories Inc.’s earnings expectationsWatch List & Consistent Income Trade Recommendations - khodrobank.com
Is Bio Rad Laboratories Inc. in a consolidation phaseMarket Activity Report & Community Verified Watchlist Alerts - khodrobank.com
What’s next for Bio Rad Laboratories Inc. stockJuly 2025 Highlights & Weekly High Return Opportunities - khodrobank.com
Is Bio Rad Laboratories Inc. a stock for growth or value investors2025 Market Sentiment & Free Verified High Yield Trade Plans - khodrobank.com
Is Bio Rad Laboratories Inc. stock risky to hold now2025 Momentum Check & Long-Term Growth Portfolio Plans - khodrobank.com
Is it Apt to Hold Bio-Rad Stock in Your Portfolio Now? - The Globe and Mail
Applying Wyckoff theory to Bio Rad Laboratories Inc. stockPortfolio Performance Summary & Long-Term Capital Growth Ideas - Newser
Is Bio Rad Laboratories Inc. stock ready for a breakoutJuly 2025 Rallies & Low Drawdown Trading Strategies - Newser
Smart tools for monitoring Bio Rad Laboratories Inc.’s price actionJuly 2025 Short Interest & Growth Focused Investment Plans - Newser
Will Bio Rad Laboratories Inc. benefit from geopolitical trends2025 Breakouts & Breakdowns & Verified Short-Term Plans - beatles.ru
What earnings revisions data tells us about Bio Rad Laboratories Inc.Market Sentiment Summary & Risk Adjusted Buy/Sell Alerts - Newser
Applying big data sentiment scoring on Bio Rad Laboratories Inc.July 2025 Update & High Yield Stock Recommendations - Newser
How institutional ownership impacts Bio Rad Laboratories Inc. stock2025 Trade Ideas & Stepwise Trade Signal Implementation - Newser
Bio Rad Laboratories Inc Azioni (BIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.38%
0.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):